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Abstract: The purpose of the studies reported here was to examine the problem of the 
effectiveness of screening for gestational diabetes mellitus. It utilises meta-analysis to 
examine the conclusions of many studies in order to come up with a practical solution to the 
problem. 
 
Keywords: Diabetes mellitus, Meta-analysis, Sensitivity, Specificity, Predictability, 
Prevalence. 
 
Introduction 
There is a lack of consistent evidence in the literature about the effectiveness of screening 
processes for diseases in general.  One of the issues is the “worried well” who do not return 
for diagnostic testing when requested after a positive screening test. In the context of 
screening and diagnostic tests for diabetes mellitus another issue is the reliability of the 
measurements of the blood glucose levels, including sometimes less than robust hospital 
conditions [5]. This paper looks at some aspects of the effectiveness of screening for 
gestational diabetes mellitus (GDM). 
 
By screening we here refer to 1 hour 50 gram and 75 gram glucose challenge tests (GCT); by 
diagnosis we here refer to 2 hour 75 gram and 3 hour 100 gram oral glucose tolerance tests 
(OGTT) [11].  Suitable testing requires a consideration of both 
•  sensitivity (the proportion of subjects with the target disorder who have a positive 
test), and  
•  specificity (the proportion of subjects without the target disorder who have a negative 
test). 
 
We shall include these in our discussion, but even more fundamentally, controversies 
surround many aspects of GDM such as the definition, diagnosis, and management of GDM, 
as well as the effects on the mother and offspring. Meta-analyses of the literature have been 
carried out but even they do not convey an unequivocal picture of appropriate procedures. 
This study, which was part of a larger investigation, is an attempt to get an overall perspective 
of what works in general, based upon studies considered by other authors in previous relevant 
studies.  
 
Given the above caveats it was felt appropriate and beneficial for discussion to take a broader 
overview of the results in the research reports cited. 
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Meta-analysis 
Meta-analysis is a statistical approach to aggregate and analyse summary statistics from a 
number of studies [4]. It is especially useful where studies disagree with regard to the 
magnitude or direction of an effect [6]. For instance, we have used the approach to compare 
glycaemic control with human and porcine insulins by means of data on glycosylated 
haemoglobin, fasting blood-glucose and mean blood-glucose levels in various reported 
studies [7] and to relate multiple injections with glycaemic control [9]. 
 
L'Abbé et al., [1] discussed the role of meta-analysis in clinical research. They pointed out 
that: 
•  meta-analysis is a systematic reviewing strategy for addressing research questions that 
is especially useful when results from several studies disagree with regard to 
magnitude or direction of effect; 
•  sample sizes may be individually too small to detect an effect and label it statistically 
significant; 
•  large trials may be too costly and time-consuming to perform; 
•  in evaluating medical treatment and planning new studies, a better understanding is 
needed of the findings of previous clinical studies. Investigators rely heavily on 
literature reviews to define the present state of knowledge. Meta-analysis takes a more 
structured approach to literature review than does traditional narrative review, and this 
way may be more helpful in evaluating the accumulation of evidence. 
 
There are three other methods of research synthesis, namely, the traditional narrative reviews, 
the vote counting methods, and the combined significance test methods. Meta-analysis is 
distinguished from these in the way it uses statistics, and from primary studies (the original 
analysis of data) and secondary analysis (reanalysis of another's data) by the fact that meta-
analyses do not require access to the raw data, but only to summary statistics. Thus the data 
points for meta-analyses are summary statistics, and a sample of studies in meta-analysis is 
analogous to a sample of subjects in primary analysis.  
 
A meta-analysis is much more structured and replicable than an ordinary narrative literature 
review. Based on Chalmers and Lau [2] we have developed a ten step procedure for 
conducting meta-analyses: 
•  development of a protocol for conducting the meta-analysis; 
•  identification of sources of information used; 
•  definition of the criteria for the selection of trials for inclusion; 
•  reading, classification, coding, scoring, evaluating and choosing of literature; 
•  adjudication of differences among readers on the qualitative criteria; 
•  development of questions, procedures, and analyses to pose of trials for inclusion; 
•  reading of papers and answering of questions on the checklists; 
•  combination of results and quality assurance of the data; 
•  analysis, interpretation and reporting of results. 
 
Results 
Meta-analysis was used to compare and, where appropriate, to combine results from more 
than 200 published studies. These were selected using Medline and periodic anthologies of 
diabetes literature. An example of combining six such groups of studies, each with more than 
200 subjects, is used. 
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Some of the parameters of this combination are displayed in the first data column of Table 1 
where reference is made to the positive predictability of the screening tests and to the 
prevalence of GDM in the combined samples. For ease of comparison, the specificity has 
been maintained at 78% and the other parameters allowed to vary. 
 
    Table 1. Comparisons of parameters (%) from meta-analyses 
Sensitivity 95  64  81 
Specificity 78  78  78 
Predictability 14  15  30 
Prevalence 4  4  8 
 
The relatively low predictability is not unexpected for a disease with relatively low 
prevalence, yet it questions the advisability of screening based on risk factors [3, 8] since 
there is evidence that historical and clinical risk factors are relatively insensitive to GDM 
because of their relatively high prevalence among healthy patients.  
 
If one argues for universal screening, then, with the same data, to achieve a predictability of 
15% the sensitivity would drop to 64%. If, as some evidence suggests [12], the prevalence is 
about 8% in some Australian communities, then one might be able to achieve a predictability 
of 30% and a sensitivity of 81%. 
 
Conclusion 
Given that nature only gives us a short window of opportunity in which to manage GDM 
effectively, even a slight degree of under-diagnosis is to be avoided. Our conclusion is to 
recommend universal testing of all pregnant women with a 75 gram OGTT at the beginning of 
the third trimester as it is during this period that the adipose and islet cells are formed in the 
unborn child [10]. Universal screening with a highly sensitive, but lowly predictable, test 
almost amounts to the same thing in practice. 
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